Cargando…
ATH434 Reverses Colorectal Dysfunction in the A53T Mouse Model of Parkinson’s Disease
BACKGROUND: Gastrointestinal (GI) complications, that severely impact patient quality of life, are a common occurrence in patients with Parkinson’s disease (PD). Damage to enteric neurons and the accumulation of alpha-synuclein in the enteric nervous system (ENS) are thought to contribute to this ph...
Autores principales: | Diwakarla, Shanti, McQuade, Rachel M., Constable, Remy, Artaiz, Olivia, Lei, Enie, Barnham, Kevin J., Adlard, Paul A., Cherny, Robert A., Di Natale, Madeleine R., Wu, Hongyi, Chai, Xin-yi, Lawson, Victoria A., Finkelstein, David I., Furness, John B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8609706/ https://www.ncbi.nlm.nih.gov/pubmed/34366375 http://dx.doi.org/10.3233/JPD-212731 |
Ejemplares similares
-
The Compound ATH434 Prevents Alpha-Synuclein Toxicity in a Murine Model of Multiple System Atrophy
por: Finkelstein, David I., et al.
Publicado: (2022) -
ATH434 Rescues Pre-motor Hyposmia in a Mouse Model of Parkinsonism
por: Beauchamp, Leah C., et al.
Publicado: (2022) -
The association of enteric neuropathy with gut phenotypes in acute and progressive models of Parkinson’s disease
por: McQuade, Rachel M., et al.
Publicado: (2021) -
Gastrointestinal Dysfunction in Parkinson’s Disease: Current and Potential Therapeutics
por: Han, Myat Noe, et al.
Publicado: (2022) -
A Critical Analysis of Intestinal Enteric Neuron Loss and Constipation in Parkinson’s Disease
por: O’Day, Chelsea, et al.
Publicado: (2022)